866-997-4948(US-Canada Toll Free)

PDS Biotechnology Corporation - Product Pipeline Review - 2014

Published By :

Global Markets Direct

Published Date : Jul 2014

Category :

Pharmaceutical

No. of Pages : 22 Pages

PDS Biotechnology Corporation - Product Pipeline Review - 2014

Summary

Global Markets Directs, PDS Biotechnology Corporation - Product Pipeline Review - 2014, provides an overview of the PDS Biotechnology Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of PDS Biotechnology Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of PDS Biotechnology Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of PDS Biotechnology Corporations human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the PDS Biotechnology Corporations pipeline products

Reasons to buy

- Evaluate PDS Biotechnology Corporations strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of PDS Biotechnology Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the PDS Biotechnology Corporations R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of PDS Biotechnology Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of PDS Biotechnology Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of PDS Biotechnology Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
PDS Biotechnology Corporation Snapshot 4
PDS Biotechnology Corporation Overview 4
Key Information 4
Key Facts 4
PDS Biotechnology Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
PDS Biotechnology Corporation - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
PDS Biotechnology Corporation - Pipeline Products Glance 11
PDS Biotechnology Corporation - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
PDS Biotechnology Corporation - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
PDS Biotechnology Corporation - Drug Profiles 13
PDS-0101 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Immunotherapies for Non-Viral Cancers 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PDS-0102 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PDS Biotechnology Corporation - Pipeline Analysis 17
PDS Biotechnology Corporation - Pipeline Products by Route of Administration 17
PDS Biotechnology Corporation - Pipeline Products by Molecule Type 18
PDS Biotechnology Corporation - Recent Pipeline Updates 19
PDS Biotechnology Corporation - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 22
Disclaimer 22

List of Tables
PDS Biotechnology Corporation, Key Information 4
PDS Biotechnology Corporation, Key Facts 4
PDS Biotechnology Corporation - Pipeline by Indication, 2014 6
PDS Biotechnology Corporation - Pipeline by Stage of Development, 2014 7
PDS Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 8
PDS Biotechnology Corporation - Partnered Products in Pipeline, 2014 9
PDS Biotechnology Corporation - Partnered Products/ Combination Treatment Modalities, 2014 10
PDS Biotechnology Corporation - Phase I, 2014 11
PDS Biotechnology Corporation - Preclinical, 2014 12
PDS Biotechnology Corporation - Pipeline by Route of Administration, 2014 17
PDS Biotechnology Corporation - Pipeline by Molecule Type, 2014 18
PDS Biotechnology Corporation - Recent Pipeline Updates, 2014 19

List of Figures
PDS Biotechnology Corporation - Pipeline by Top 10 Indication, 2014 6
PDS Biotechnology Corporation - Pipeline by Stage of Development, 2014 7
PDS Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 8
PDS Biotechnology Corporation - Pipeline by Top 10 Route of Administration, 2014 17
PDS Biotechnology Corporation - Pipeline by Top 10 Molecule Type, 2014 18

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Blood-Brain Barrier Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

    Blood-brain barrier is the lining of endothelial cells covering the capillaries of the brain. Some of the functions of these blood-brain barriers are as follows: Protecting brain health by preventing pathogens (most common infectious bacteria and viruses and other pathogens) from entering the brain Excluding and metabolizing neurotoxic compounds (drugs, antibodies and plasma proteins) and neurotransmitters from brain and blood Safeguar...

  • Poland: sterilizers market

    This report presents a comprehensive overview of the sterilizers market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the sterilizers market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the p...

  • Central Nervous System Disorder Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    The market for central nervous system disorder drugs comprise of drugs used for the treatment of diseases affecting the brain or spinal cord such as epilepsy, Parkinson’s disease, Alzheimer’s disease, depression, anxiety and bipolar disorders. Epilepsy is a chronic brain disorder characterized by recurring seizures. Parkinson’s disease is a degenerative CNS disorder associated with symptoms including tremor, rigidity, akinesia...